Research Article
Prevalence, Clinical Correlates, and Use of Glucose-Lowering Drugs among Older Patients with Type 2 Diabetes Living in Long-Term Care Facilities
Table 1
Characteristics of diabetic patients living in long-term facilities.
| Age (years) | | Total | 82.9 ± 2.1 | Male | 80.7 ± 2.2 | Female | 83.9 ± 1.9 | Females | 582 (67.4%) | BMI | | ≤18 | 46 (5.3%) | 18–24.9 | 382 (44.3%) | 25–29.9 | 206 (23.9%) | ≥30 | 98 (11.4%) | N.D. | 131 (15.1%) | Preprandial serum glucose | | ≤70 mg/dL | 47 (5.5%) | 71–126 mg/dL | 398 (46.1%) | 127–180 mg/dL | 224 (25.9%) | ≥181 mg/dL | 153 (17.7%) | N.D. | 41 (4.8%) | HbA1c | | <7% | 354 (54.9%) | 7–8.5% | 131 (20.4%) | >8.5% | 159 (24.7%) | Functional dependence | | Partial (ADL = 1) | 435 (50.4%) | Total (ADL ≥ 2) | 291 (33.7%) | Moderate-severe cognitive impairment (MMSE ≤ 18) | 616 (71.4%) | Comorbidities | | 0 | 7 (0.8%) | 1-2 | 261 (30.3%) | 3-4 | 388 (44.9%) | ≥5 | 207 (24.0%) |
|
|